Renalytix plc (RNLXY): Total Liabilities
Not updated since 2024-06-30. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$15.83M
As of 2024-06-30
$16.11M
As of 2024-09-30
+30.5%
3-year compound annual growth
+69.0%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2024-06-30 | $15.83M | -33.1% | 2024-09-30, Balance as of period end |
| 2023-06-30 | $23.66M | +21.6% | 2024-09-30, Balance as of period end |
| 2022-06-30 | $19.46M | +173.5% | 2023-09-28, Balance as of period end |
| 2021-06-30 | $7.12M | +43.1% | 2022-10-31, Balance as of period end |
| 2020-06-30 | $4.97M | +332.6% | 2022-08-01, Balance as of period end |
| 2019-06-30 | $1.15M | +86.2% | 2022-08-01, Balance as of period end |
| 2018-06-30 | $617.0K | n/a | 2020-11-10, Balance as of period end |